Sheldon L. Wallerstein is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of enzymatic transamination, holding a total of 2 patents. His work focuses on the preparation of amino-cyclopamines, which are important in various biochemical applications.

Latest Patents

Wallerstein's latest patents include the invention titled "Enzymatic transamination of cyclopamine analogs." This invention relates to the preparation of amino-cyclopamines through the enzymatic transamination of corresponding keto-cyclopamines in the presence of a cofactor and an amino donor. This innovative approach has the potential to advance the synthesis of important compounds in medicinal chemistry.

Career Highlights

Wallerstein is currently associated with Infinity Pharmaceuticals, Inc., where he continues to explore and develop new methodologies in the field of enzymatic reactions. His expertise and innovative spirit have positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Throughout his career, Wallerstein has collaborated with talented individuals such as Brian C. Austad and Adilah Bahadoor. These collaborations have fostered a creative environment that encourages the development of groundbreaking inventions.

Conclusion

Sheldon L. Wallerstein's contributions to enzymatic transamination highlight his role as an influential inventor in the pharmaceutical field. His innovative patents and collaborations continue to pave the way for advancements in biochemistry.

This text is generated by artificial intelligence and may not be accurate.